Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 13, 2010Antimicrobial Agents and ChemotherapyOpen Access

Population Pharmacokinetics of Doripenem Based on Data from Phase 1 Studies with Healthy Volunteers and Phase 2 and 3 Studies with Critically Ill Patients

View Full Paper
Ask AI
Bookmark
Share

Authors

PNPartha NandyMSMahesh N. SamtaniRLRachel Lin

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Nandy et al. (2010) studied this question.

synapsesocial.com/papers/6a9304aad10fd8fa3bf0b35fhttps://doi.org/10.1128/aac.01649-09
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1In Vitro Activity of Doripenem, a Carbapenem for the Treatment of Challenging Infections Caused by Gram-Negative Bacteria, against Recent Clinical Isolates from the United States2008 · 78 citations
  2. 2Population pharmacokinetics of imipenem in burn patients2003 · 41 citations
  3. 3Use of Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Support Phase 2 and 3 Dosing Strategies for Doripenem2005 · 123 citations
  4. 4Generalized Additive Models1986 · 3,476 citations